Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Airline safe toothpaste

This article was originally published in The Tan Sheet

Executive Summary

Belmont, Calif.-based DentaKit is marketing its pre-pasted disposable ReadyBrush as a toothpaste alternative for travelers, according to an Aug. 12 release. The individually packaged toothbrushes are treated with water-activated powdered toothpaste making them compliant with the new airline security regulations, the firm says. The brushes are available in Delux and Ortho, $1.10 each or $27 for 30, and Regular, $.65 each or $45.99 for 100. ReadyBrush has been featured on The Today Show and in the New York Times. The new TSA security procedures were issued Aug. 13 (1"The Tan Sheet" Aug. 21, 2006, In Brief). Three days later, Procter & Gamble announced it would offer Crest Smile Packs featuring products from its Pro-Health and Glide lines at select Avis car rental locations near airports (2"The Tan Sheet" Aug. 21, 2006, In Brief)...

You may also be interested in...

OTCs in carry-ons

Four ounces of non-prescription liquid medications, up to five ounces of low blood sugar treatments and small amounts of breast milk and baby formula will be allowed in carry-on bags according to the new TSA security procedures issued Aug. 13. Breast milk and baby formula will only be allowed if a passenger is traveling with a baby or toddler. All items including medication will be x-rayed unless a passenger asks for visual inspection...

QUOTED. 3 April 2020. Minetta Liu.

Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.

Colorectal, Bladder Cancer Therapies Are Top Prospects For April US FDA Approvals

Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts